GeneReach Biotechnology (Taiwan) Probability of Future Stock Price Finishing Under 27.25
| 4171 Stock | TWD 27.25 1.10 3.88% |
GeneReach |
GeneReach Biotechnology Target Price Odds to finish below 27.25
The tendency of GeneReach Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 27.25 | 90 days | 27.25 | roughly 2.2 |
Based on a normal probability distribution, the odds of GeneReach Biotechnology to move below current price in 90 days from now is roughly 2.2 (This GeneReach Biotechnology probability density function shows the probability of GeneReach Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon GeneReach Biotechnology has a beta of -0.0145. This suggests as returns on the benchmark increase, returns on holding GeneReach Biotechnology are expected to decrease at a much lower rate. During a bear market, however, GeneReach Biotechnology is likely to outperform the market. Additionally GeneReach Biotechnology has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. GeneReach Biotechnology Price Density |
| Price |
Predictive Modules for GeneReach Biotechnology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as GeneReach Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.GeneReach Biotechnology Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. GeneReach Biotechnology is not an exception. The market had few large corrections towards the GeneReach Biotechnology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold GeneReach Biotechnology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of GeneReach Biotechnology within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.22 | |
β | Beta against Dow Jones | -0.01 | |
σ | Overall volatility | 1.26 | |
Ir | Information ratio | -0.28 |
GeneReach Biotechnology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of GeneReach Biotechnology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for GeneReach Biotechnology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| GeneReach Biotechnology generated a negative expected return over the last 90 days | |
| About 35.0% of the company shares are owned by insiders or employees |
GeneReach Biotechnology Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of GeneReach Stock often depends not only on the future outlook of the current and potential GeneReach Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. GeneReach Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 41.8 M |
GeneReach Biotechnology Technical Analysis
GeneReach Biotechnology's future price can be derived by breaking down and analyzing its technical indicators over time. GeneReach Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of GeneReach Biotechnology. In general, you should focus on analyzing GeneReach Stock price patterns and their correlations with different microeconomic environments and drivers.
GeneReach Biotechnology Predictive Forecast Models
GeneReach Biotechnology's time-series forecasting models is one of many GeneReach Biotechnology's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary GeneReach Biotechnology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about GeneReach Biotechnology
Checking the ongoing alerts about GeneReach Biotechnology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for GeneReach Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| GeneReach Biotechnology generated a negative expected return over the last 90 days | |
| About 35.0% of the company shares are owned by insiders or employees |
Additional Tools for GeneReach Stock Analysis
When running GeneReach Biotechnology's price analysis, check to measure GeneReach Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneReach Biotechnology is operating at the current time. Most of GeneReach Biotechnology's value examination focuses on studying past and present price action to predict the probability of GeneReach Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneReach Biotechnology's price. Additionally, you may evaluate how the addition of GeneReach Biotechnology to your portfolios can decrease your overall portfolio volatility.